Indications for referral to secondary care

Introduction:

Individuals at very high fracture risk may benefit from early clinical review by osteoporosis specialists to consider first line anabolic therapy. NOGG have suggested a number of criteria on which referral to secondary care should be considered.

 

Resource:

Consider referral of very high fracture risk patients to an osteoporosis specialist in secondary care, for assessment and consideration of parenteral treatment (some may need first-line anabolic drug treatment, especially those with multiple vertebral fractures). Indications for specialist referral include:

    • The presence of single but important clinical risk factors, such as,
      • A recent vertebral fracture [within the last 2 years]
      • ≥2 vertebral fractures [whenever they have occurred]
      • BMD T-Score ≤-3.5
      • Treatment with high dose glucocorticoids [≥7.5 mg/day of prednisolone or equivalent over 3 months] (refer urgently given rapid loss in bone post initiation of glucocorticoids; if any delay is anticipated, start an oral bisphosphonate in the meantime)
    • The presence of multiple clinical risk factors, particularly with a recent fragility fracture indicating high imminent risk of re-fracture.
    • Or other indicators of very high fracture risk.

 

Related Information:

Link:

https://www.nogg.org.uk/full-guideline/section-4-intervention-thresholds-and-strategy (recommendation 8)

 

Reference:

National Osteoporosis Guideline Group (NOGG) UK. Clinical Guideline for the Prevention and Treatment of Osteoporosis, https://www.nogg.org.uk/full-guideline (2021, accessed 28 March 2024).